RxDoctor Payments Data

Kaitlyn Sizemore

Physician Assistant · Eaton, OHNPI 1891163580

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 344 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,727in general payments, 2019–2025

Across 344 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$902
  • Novo Nordisk$693
  • AbbVie$668
  • Johnson & Johnson$388
  • Astellas Pharma US Inc$382
  • Alkermes, Inc.$217
  • plus $2K from 40 others

What the payments were for

  • Food & beverage$5,56297%
  • Education$1663%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,727 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio →

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide60$72,684
FarxigaDapagliflozin Propanediol72$70,098
EliquisApixaban58$46,428
OzempicSemaglutide33$46,289
MyrbetriqMirabegron44$29,452
JardianceEmpagliflozin34$25,727
Breztri AerosphereBudesonide/Glycopyr/Formoterol32$21,551
XareltoRivaroxaban15$19,590
LinzessLinaclotide24$19,294
VascepaIcosapent Ethyl13$9,828
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$9,058
GemtesaVibegron18$8,794
Repatha SureclickEvolocumab14$7,883
LantusInsulin Glargine,hum.Rec.Anlog15$2,396
Atorvastatin Calcium301$2,298

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$902$91,650104 claims
Lilly USA, LLCMounjaro$175$72,68460 claims
PfizerEliquis$137$46,42858 claims
Novo NordiskOzempic$693$46,28933 claims
Astellas Pharma US IncMyrbetriq$382$29,45244 claims
Boehringer IngelheimJardiance$77$25,72734 claims
AbbVieLinzess, Synthroid$668$20,47749 claims
Johnson & JohnsonXarelto$388$19,59015 claims
Sumitomo Pharma America, Inc.Gemtesa$61$8,79418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Eaton

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →